文献速递抗栓抗凝管理药物不良反应与药物警戒

心脏外科患者肝素诱导性血小板减少症风险评分系统的比较

Comparison of risk-scoring systems for heparin-induced thrombocytopenia in cardiac surgery patients.
PubMed 文献 · Pharmacotherapy · 2021-10-26

该嵌套病例对照研究在心脏外科术后患者中验证并比较了改良4T(m4T)评分与Lillo-Le Louet(LLL)评分对肝素诱导性血小板减少症(HIT)的筛查性能,纳入18例HIT阳性病例和54例匹配的HIT阴性对照。m4T与LLL的c统计量分别为0.76和0.63(P=0.051),敏感性分别为61%和94%,特异性分别为91%和32%。结论认为两评分区分性能中等,但LLL评分可能更安全地用于排除HIT。

要点

  • m4T评分c统计量0.76,敏感性61%,特异性91%。
  • LLL评分c统计量0.63,敏感性94%,特异性32%。
  • LLL评分高敏感性或更适于心脏外科术后排除HIT。

核心结论

  • m4T与LLL评分在心脏外科术后患者中区分HIT阳性与阴性的性能均中等。
  • 两评分敏感性差异提示LLL评分可能更安全地用于排除HIT。

研究设计与样本

  • 嵌套病例对照研究,纳入18例HIT阳性病例和54例匹配的HIT阴性对照。
  • 回顾性计算m4T评分和心脏外科特异性LLL评分,比较c统计量、敏感性和特异性。

主要发现

  • HIT阳性组从手术至HIT检测医嘱的中位时间为9.5天(IQR 3.75-11.0),HIT阴性组为2天(IQR 2.0-3.0),P<0.0001。
  • m4T评分c统计量为0.76(95%CI 0.64-0.85),LLL评分c统计量为0.63(95%CI 0.51-0.74),P=0.051。
  • m4T评分敏感性61%、特异性91%;LLL评分敏感性94%、特异性32%。

临床怎么用

  • 在心脏外科术后怀疑HIT时,可考虑使用LLL评分因其高敏感性有助于排除HIT。
  • m4T评分特异性较高但敏感性较低,阴性结果不能单独排除HIT。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Several risk-scoring tools have been developed to exclude heparin-induced thrombocytopenia (HIT) in patients with thrombocytopenia, but these scores have not been reproduced or compared in the cardiac surgery population. The objective of this study was to validate and compare the modified 4T's (m4T) and Lillo-Le Louet (LLL) scores for HIT screening in the cardiac surgery population. METHODS: In this nested case-control study, we retrospectively calculated the m4T and the cardiac surgery-specific score by LLL for 18 cases (HIT-positive) and 54 matched controls (HIT-negative) using characteristics known at the time the HIT assay was ordered post-cardiac surgery and compared their performances by their c-statistic (area under the receiver operating characteristic curve), sensitivity and specificity. RESULTS: The median time from surgery to HIT assay order was 9.5 days (IQR 3.75-11.0) in the HIT-positive group and 2 days (IQR 2.0-3.0) in the HIT-negative group (p < 0.0001). The c-statistics for the m4T and the LLL scores were 0.76 (95% CI 0.64-0.85) and 0.63 (95% CI 0.51-0.74), respectively (p = 0.051). Sensitivity and specificity were 61% and 91% for the m4T, and 94% and 32% for the LLL score. CONCLUSION: Performance of the m4T and LLL scores in discriminating HIT-positive from HIT-negative patients was modest among patients post-cardiac surgery. However, differences between the sensitivities of these scores suggest that the LLL score may be a safer tool for ruling out HIT in this population.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Stewart JJ, Turgeon R, Parker A, et al. Comparison of risk-scoring systems for heparin-induced thrombocytopenia in cardiac surgery patients. Pharmacotherapy. 2021. PMID: 34665467. doi:10.1002/phar.2636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。